Japan Lifeline Co., Ltd.

Equities

7575

JP3754500001

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-24 EDT			5-day change	1st Jan Change
1,134 ^JPY	+1.43%		-4.22%	-10.21%

05-23	Japan Lifeline Co., Ltd. Proposes Dividend for the Fiscal Year Ended March 31, 2024	CI
05-03	Japan Lifeline's Attributable Profit Grows 9% in Fiscal Year Ended March	MT

Japan Lifeline Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2023

November 02, 2022 at 02:10 am

Japan Lifeline Co., Ltd. provided earnings guidance for the year ending March 31, 2023. For the year, the company expects net sales of JPY 51,527 million, operating profit of JPY 10,011 million, profit attributable to owners of parent JPY 7,274 million and basic earnings per share of JPY 93.06.

Latest news about Japan Lifeline Co., Ltd.

Japan Lifeline Co., Ltd. Proposes Dividend for the Fiscal Year Ended March 31, 2024	05-23	CI
Japan Lifeline's Attributable Profit Grows 9% in Fiscal Year Ended March	05-03	MT
Japan Lifeline to Launch Tender Offer for Treasury Shares	05-03	MT
Japan Lifeline to Dispose of 183 Million Yen Treasury Shares as Restricted Stock Compensation	05-03	MT
Japan Lifeline Co., Ltd. announces an Equity Buyback for 5,500,100 shares, representing 7.34% for ¥5,747.6 million.	05-01	CI
Japan Lifeline Co., Ltd. authorizes a Buyback Plan.	04-30	CI
Japan Lifeline Completes Cancellation of 7.16 Million Shares	03-13	MT
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023.	03-01	CI
Japan Lifeline Co., Ltd.'s Equity Buyback announced on May 10, 2023, has closed with 3,000,000 shares, representing 3.9% for ¥3,319.77 million.	02-28	CI
Japan Lifeline Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024	02-02	CI
Japan Lifeline Co., Ltd. Announces the Appointment of Nobuo Takahashi as Operating Officer, Associate Executive Manager of CVG Business Unit	01-31	CI
Japanese Shares Return to Green on Upbeat Economic Data	01-05	MT
Japan Lifeline Buys Back Shares Worth Over 217 Million Yen	01-04	MT
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023.	01-04	CI
Japan Lifeline Buys Back 244,300 Shares for 272.88 Million Yen	12-04	MT
Japan Lifeline Co., Ltd. Announces Management Changes	12-01	CI
Japan Lifeline Raises Forecasts for Fiscal 2024 After Better than Expected First Half	11-07	MT
Japan Lifeline Co., Ltd. Revises Year End Dividend Guidance for the Fiscal Year 2024	11-06	CI
Japan Lifeline Co., Ltd. Revises Consolidated and Non-Consolidated Earnings Guidance for the Fiscal Year Ending 31, 2024	11-06	CI
Japan Lifeline Co., Ltd. Enters into Exclusive Distribution Agreement with Meril Life Sciences Pvt. Ltd	23-10-27	CI
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023.	23-10-02	CI
Japan Lifeline Completes Disposal of 69,000 Shares for 68.31 Million Yen	23-08-25	MT
Japan Lifeline Launches Open Stent Graft Product	23-08-22	MT
Japan Lifeline Co., Ltd. Announces That It Will Start Selling A New Lineup of Its Proprietary Open Stent Graft Product Frozenix Partial ET from August 2023	23-08-21	CI
Japanese Shares Gain on Upbeat Performance of Manufacturing, Transport, Railway and Bus Sectors	23-08-10	MT

Chart Japan Lifeline Co., Ltd.

Duration

Period

More charts

Company Profile

Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-30 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Japan Lifeline Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

1,134 JPY

Average target price

1,392 JPY

Spread / Average Target

+22.72%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
JAPAN LIFELINE CO., LTD.	-10.21%	541M
STRYKER CORPORATION	+12.05%	128B
SMITH & NEPHEW PLC	-9.24%	10.88B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.29%	8.76B
GLAUKOS CORPORATION	+36.99%	5.48B
INSPIRE MEDICAL SYSTEMS, INC.	-21.98%	4.72B
AXONICS, INC.	+8.02%	3.43B
ENOVIS CORPORATION	-10.32%	2.76B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-12.33%	2.06B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-13.53%	1.92B

Medical Devices & Implants